Showing results (61-70 of 180) with videos related to
Sort By:
Pageof 18
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.Annals of Surgical Oncology|January 7, 2016
Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on CirrhosisJean-Charles Nault, Gisèle Nkontchou, Pierre Nahon, et al.Journal of Hepatology|August 17, 2019
Natural history of liver adenomatosis: A long-term observational studyLouise Barbier, Jean-Charles Nault, Fanny Dujardin, et al.Abdominal Radiology (New York)|April 14, 2022
Evaluation of perfusion CT and dual-energy CT for predicting microvascular invasion of hepatocellular carcinomaMaïté Lewin, Astrid Laurent-Bellue, Christophe Desterke, et al.Immunotherapy|July 16, 2019
Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanomaAndreea Cǎlugǎreanu, Pierre Rompteaux, Gérôme Bohelay, et al.JHEP Reports : Innovation in Hepatology|September 30, 2020
Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosisChristian Hobeika, Jean Charles Nault, Louise Barbier, et al.Annals of Surgical Oncology|June 1, 2026
AFP Model Predicts Outcomes After Liver Resection: A Multicenter Retrospective Cohort StudyBelkacem Acidi, Chetana Lim, Christian Hobeika, et al.Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.Liver Cancer|June 14, 2019
Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term ResultsGisele N'Kontchou, Jean-Charles Nault, Olivier Sutter, et al.JHEP Reports : Innovation in Hepatology|November 11, 2024
Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studiesClaudia Campani, Dimitrios Pallas, Sabrina Sidali, et al.Pageof 18